Danyan Cao

机构：Chinese Academy of Sciences, Shanghai Institute of Materia Medica, State Key Laboratory of Chemical Engineering · ORCID：0000-0002-7716-1000

发表论文 30 篇 · 总被引 531 次 · h-index 14

代表论文

• Fragment-Based Drug Discovery of 2-Thiazolidinones as BRD4 Inhibitors: 2. Structure-Based Optimization (2015 · Journal of Medicinal Chemistry · 被引 50)
• Structure-Based Discovery of Potent CARM1 Inhibitors for Solid Tumor and Cancer Immunology Therapy (2021 · Journal of Medicinal Chemistry · 被引 40)
• Structure-Based Discovery and Development of a Series of Potent and Selective Bromodomain and Extra-Terminal Protein Inhibitors (2019 · Journal of Medicinal Chemistry · 被引 38)
• Discovery of a series of dihydroquinoxalin-2(1H)-ones as selective BET inhibitors from a dual PLK1-BRD4 inhibitor (2017 · European Journal of Medicinal Chemistry · 被引 36)
• Fragment-based drug discovery of triazole inhibitors to block PDEδ-RAS protein-protein interaction (2018 · European Journal of Medicinal Chemistry · 被引 29)
• Design and Synthesis of Potent, Selective Inhibitors of Protein Arginine Methyltransferase 4 against Acute Myeloid Leukemia (2019 · Journal of Medicinal Chemistry · 被引 27)